Oregon State University researchers developed Thio-lipids, lipid nanoparticles targeting lungs and eyes.

The nanoparticles can deliver messenger RNA for gene therapy in conditions like cystic fibrosis and genetic blindness.

Thio-lipids have been effective in treating pulmonary disease and genetic blindness in animal models.

The study was funded by the National Eye Institute and could lead to new treatments for retinal and pulmonary genetic diseases.

Further research is necessary to assess the long-term effects of Thio-lipids on retinal health.